Keywords
Cachexia
Functional capacity
Malnutrition
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To assess the nutritional status and functional capacity of hospitalized cancer patients in a referral hospital. Methods: This is a cross-sectional study involving cancer patients hospitalized between June and November 2024. Clinical and anthropometric variables, cancer cachexia stages, performance status, and blood glucose levels were evaluated. Results: The sample included 48 patients, with a mean age of 56.6 years (±13.4); most were female (68.8%) and had tumors located in the reproductive system (39.6%) at stage III of the disease, indicating an advanced cancer stage. Regarding nutritional status, based on Body Mass Index (BMI), 25% were underweight or malnourished, 35.4% showed impaired functional capacity, and 75% were diagnosed with cachexia. A negative correlation was found between (BMI) and cachexia stages (r = -0.304; p= 0.036), and a positive correlation between weight loss and cachexia stages (r= 0.702; p< 0.001). Conclusion: Cachexia is a significant complication in cancer patients, highlighting the need for an integrated approach that considers both nutritional and functional aspects to prevent or manage functional decline.
References
ARGILÉS JM, et al. Cancer cachexia: understanding the molecular basis. Nature Reviews Cancer. 2014; 14(11): 754–762.
ABCP. ASSOCIAÇÃO BRASILEIRA DE CUIDADOS PALIATIVOS. Consenso Brasileiro de Caquexia e Anorexia em Cuidados Paliativos. Rev Bras Cuidados Paliativos, 2011; 3(3-1): 3–42.
BARACOS VE, et al. Cancer-associated cachexia. Nat Rev Dis Primers, 2018; 4: 17105.
BARONE B, et al. Cetoacidose diabética em adultos: atualização de uma complicação antiga. Arq Bras Endocrinol Metabol, 2007; 51(9): 1434–47.
BLACKBURN GL e THORNTON PA. Nutritional assessment of the hospitalized patient. Med Clin North Am, 1979; 63: 1103–15.
BRASIL. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Regulação, Avaliação e Controle. Coordenação-geral de Gestão dos Sistemas de Informações em Saúde. Manual de bases técnicas da oncologia: SIA/SUS Sistema de Informações Ambulatoriais. 28. ed. Brasília, DF: Ministério da Saúde; set. 2021.Disponível em: https ://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/image//capa_manual_30_ed .jpg. Acessado em: 13 de junho de 2025.
CRUZ-JENTOFT AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing, 2018; 48(1): 16–31.
DUVAL PA, et al. Prevalência de caquexia neoplásica e fatores associados na internação domiciliar. Rev Bras Cancerol, 2015; 61(3): 261–7.
FEARON K, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol, 2011; 12(5): 489–95.
FRISANCHO AR. Anthropometric Standards for the Assessment of Growth and Nutritional Status. Michigan: University of Michigan Press, 1990.
GAAFAR O e ZIMMERS T. Nutrition challenges of cancer cachexia. JPEN J Parenter Enteral Nutr, 2021; 45(2): 16–25.
INCA. INSTITUTO NACIONAL DE CÂNCER JOSÉ ALENCAR GOMES DA SILVA. ABC do câncer: abordagens básicas para o controle do câncer. 6. ed. rev. atual. Rio de Janeiro: INCA; 2020. Disponível em: https ://www.in ca.gov.br/sites/ufu.sti.inca.local/files//media/document/livro_abc_6ed_0.pdf. Acessad o em 15 de maio de 2025.
KAZEMI-BAJESTANI SMR, et al. Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes. Semin Cell Dev Biol, 2016; 54: 2–10.
KOWATA CH, et al. Fisiopatologia da caquexia no câncer: uma revisão. 2009.
MARTIN L, et al. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J Cachexia Sarcopenia Muscle, 2021; 12(5): 1189–1202.
NASCIMENTO GV, et al. Efeito do treinamento resistido e suplementação com HMB no tratamento da caquexia do câncer. RBNE – Revista Brasileira de Nutrição Esportiva, 2015; 5(29).
NI J e ZHANG L. Cancer Cachexia: Definition, Staging, and Emerging Treatments. Cancer Manag Res, 2020; 12: 5597–605.
OMS. GLOBOCAN. Número estimado de novos casos em 2020, ambos os sexos, todas as idades – 2020.Disponível em: https ://iris.who.int/bitstream/handle/10665/332070/9789240005105-eng.pdf?sequ ence=1. Acessado em: 25 de maio de 2025.
OPAS. Encuesta Multicéntrica Salud Bienestar y Envejecimiento (SABE) en América Latina y el Caribe: Informe Preliminar. Kingston: OPAS; 2002. Disponível em: https ://pesquisa.bvsalud.org/portal/resourc e/pt/lil-381614. Acessado em: 10 de maio de 2025.
PETERSON SJ e MOZER M. Differentiating Sarcopenia and Cachexia Among Patients With Cancer. Nutr Clin Pract. 2017; 32(1): 30–9.
RÉSIMONT G, et al. Urinary strips for protein assays: easy to do but difficult to interpret! J Nephrol, 2021; 34(2): 411–32.
SILVA MPN da. Síndrome da anorexia-caquexia em portadores de câncer. Rev Bras Cancerol, 2006; 52(1): 5977.
SBD. SOCIEDADE BRASILEIRA DE DIABETES. Diretrizes da Sociedade Brasileira de Diabetes 2019-2020. Clannad; 2019. Disponível em: file :///C:/Users/daniellacfc/Downloads/Diretrizes-Sociedade-Brasileira-de-Diabetes-2019-20201.pdf. Acessado em: 28 de abril de 2025.
TORRES TA e SALOMON ALR. Estado nutricional e consumo alimentar de pacientes em tratamento de câncer. Braspen Journal, 2020; 34(4): 384–390.
WEST H e JIN JO. Performance Status in Patients With Cancer. JAMA Oncol, 2015; 1(7): 998.
WHO. Physical Status: the use and interpretation of anthropometry. Switzerland: WHO Technical Report Series, 1995.
ZUBROD CG, et al. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis, 1960; 11: 7–33.